Try our beta test site
132 studies found for:    Kaiser Permanente | Open Studies | cancer
Show Display Options
RSS Create an RSS feed from your search for:
Kaiser Permanente | Open Studies | cancer
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Implementing Systematic Distress Screening in Breast Cancer
Condition: Breast Cancer
Intervention: Behavioral: Distress screening
2 Recruiting Strategies and Opportunities to Stop Colon Cancer in Priority Populations
Condition: Colorectal Cancer
Intervention: Other: Auto Plus
3 Recruiting Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects
Conditions: Cancer of the Breast;   Anomaly of Breast
Interventions: Procedure: Autologous Fat Grafting of the Breast;   Other: Control Arm
4 Not yet recruiting POEM (Practice Of Embracing Each Moment) STUDY
Conditions: Distress;   Cancer;   Chemotherapy Effect
Interventions: Behavioral: Mindfulness meditation program (administered via mobile app);   Behavioral: Progressive muscle relaxation (via mobile app)
5 Recruiting Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers
Conditions: Caregiver;   Psychological Impact of Cancer and Its Treatment;   Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Other: Palliative Therapy;   Other: quality-of-life assessment;   Other: questionnaire administration
6 Not yet recruiting The Watch the Spot Trial
Conditions: Solitary Pulmonary Nodule;   Coin Lesion, Pulmonary;   Lung Neoplasms;   Carcinoma, Non-small-cell Lung
Interventions: Other: More Frequent Surveillance Strategy;   Other: Less Frequent Surveillance Strategy
7 Recruiting PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX (chemotherapy);   Other: 5 FUCMT (chemoradiation);   Procedure: surgery;   Procedure: magnetic resonance imaging or endorectal ultrasound
8 Recruiting S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: everolimus;   Drug: exemestane;   Drug: goserelin acetate;   Drug: letrozole;   Drug: leuprolide acetate;   Drug: tamoxifen citrate;   Other: placebo
9 Recruiting Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Condition: Lung Cancer
Interventions: Radiation: Standard Radiation Dose Therapy;   Drug: cisplatin;   Drug: etoposide;   Radiation: High Radiation Dose Therapy;   Drug: carboplatin
10 Recruiting S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: TAK-700;   Drug: Bicalutamide
11 Recruiting CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers
Conditions: Breast Carcinoma;   Cervical Carcinoma;   Colorectal Carcinoma;   Health Status Unknown;   Human Papillomavirus Infection;   Malignant Neoplasm
Intervention: Other: Informational Intervention
12 Recruiting PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Palbociclib;   Drug: Standard Adjuvant Endocrine Therapy
13 Recruiting Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Procedure: Axillary Lymph Node Dissection (ALND);   Radiation: Nodal Radiation Therapy;   Radiation: Axillary Radiation Therapy
14 Recruiting Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: radiation therapy;   Radiation: Whole-pelvic radiotherapy (WPRT)
15 Recruiting Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
Condition: Malignant Neoplasm
Intervention: Other: Laboratory Biomarker Analysis
16 Recruiting A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Neoplasms
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Atezolizumab;   Drug: Bevacizumab;   Drug: Atezolizumab Placebo
17 Recruiting S1204, Viral Screening in Newly Diagnosed Cancer Patients
Condition: Cancer
Intervention:
18 Recruiting A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
Condition: Triple Negative Breast Cancer
Interventions: Drug: Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody;   Drug: Nab-Paclitaxel;   Drug: Placebo
19 Recruiting Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Atezolizumab;   Drug: Cisplatin;   Drug: Vinorelbine;   Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Pemetrexed
20 Recruiting A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-paclitaxel Compared With Carboplatin + Nab-paclitaxel in Participants With Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) [IMpower 131]
Condition: Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody;   Drug: Carboplatin;   Drug: Nab-paclitaxel;   Drug: Paclitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.